These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17456480)

  • 21. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.
    Scirica BM; Morrow DA; Budaj A; Dalby AJ; Mohanavelu S; Qin J; Aroesty J; Hedgepeth CM; Stone PH; Braunwald E
    J Am Coll Cardiol; 2009 Apr; 53(16):1411-21. PubMed ID: 19371824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of bleeding and blood transfusion in percutaneous coronary intervention.
    Rao SV
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S18-26. PubMed ID: 17917617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.
    Lopes RD; Pieper KS; Horton JR; Al-Khatib SM; Newby LK; Mehta RH; Van de Werf F; Armstrong PW; Mahaffey KW; Harrington RA; Ohman EM; White HD; Wallentin L; Granger CB
    Heart; 2008 Jul; 94(7):867-73. PubMed ID: 18332062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes.
    Dabbous OH; Anderson FA; Gore JM; Eagle KA; Fox KA; Mehta RH; Goldberg RJ; Agnelli G; Steg PG;
    Heart; 2008 Feb; 94(2):159-65. PubMed ID: 17575335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
    Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
    Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes.
    Alexander KP; Chen AY; Wang TY; Rao SV; Newby LK; LaPointe NM; Ohman EM; Roe MT; Boden WE; Harrington RA; Peterson ED;
    Am Heart J; 2008 Jun; 155(6):1047-53. PubMed ID: 18513518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute medical management of the non-ST-segment elevation acute coronary syndromes (NSTE-ACS) in older patients.
    Docherty A
    Arch Gerontol Geriatr; 2010; 51(2):129-34. PubMed ID: 19819566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
    Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A;
    Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The emerging role of platelet glycoprotein IIb/IIIa inhibitors in managing high-risk patients with non-ST segment elevation acute coronary syndromes.
    Bolognese L
    Curr Med Res Opin; 2007 Jun; 23(6):1217-26. PubMed ID: 17559721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III.
    Cohen M; Diez JE; Levine GN; Ferguson JJ; Morrow DA; Rao SV; Zidar JP; ;
    J Invasive Cardiol; 2007 Dec; 19(12):525-38; quiz 539-40. PubMed ID: 18180524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice.
    Wang TY; Ou FS; Roe MT; Harrington RA; Ohman EM; Gibler WB; Peterson ED
    Circulation; 2009 May; 119(18):2454-62. PubMed ID: 19398666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of antithrombotics for acute coronary syndromes in the emergency department: considerations and impact.
    Mukherjee D; Eagle KA
    Prog Cardiovasc Dis; 2007; 50(3):167-80. PubMed ID: 17976502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of bleeding in 'real-life' acute coronary syndrome patients treated with antithrombotic therapy.
    Mortensen J; Thygesen SS; Johnsen SP; Vinther PM; Kristensen SD; Refsgaard J
    Cardiology; 2008; 111(1):41-6. PubMed ID: 18239391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes.
    Melloni C; Alexander KP; Chen AY; Newby LK; Roe MT; Allen LaPointe NM; Pollack CV; Gibler WB; Ohman EM; Peterson ED;
    Am Heart J; 2008 Aug; 156(2):209-15. PubMed ID: 18657648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiative.
    Spinler SA; Ou FS; Roe MT; Gibler WB; Ohman EM; Pollack CV; Alexander KP; Peterson ED
    Pharmacotherapy; 2009 Jun; 29(6):631-8. PubMed ID: 19476416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb.
    Mehta RH; Rao SV; Ohman EM; Bates ER; Marcucci G; Zhang M; Pieper KS; Armstrong PW; White HD; Van de Werf F; Califf RM; Granger CB
    Eur Heart J; 2008 Apr; 29(7):880-7. PubMed ID: 18334473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology.
    Steg PG; Huber K; Andreotti F; Arnesen H; Atar D; Badimon L; Bassand JP; De Caterina R; Eikelboom JA; Gulba D; Hamon M; Helft G; Fox KA; Kristensen SD; Rao SV; Verheugt FW; Widimsky P; Zeymer U; Collet JP
    Eur Heart J; 2011 Aug; 32(15):1854-64. PubMed ID: 21715717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arterial access-site-related outcomes of patients undergoing invasive coronary procedures for acute coronary syndromes (from the ComPaRison of Early Invasive and Conservative Treatment in Patients With Non-ST-ElevatiOn Acute Coronary Syndromes [PRESTO-ACS] Vascular Substudy).
    Sciahbasi A; Pristipino C; Ambrosio G; Sperduti I; Scabbia EV; Greco C; Ricci R; Ferraiolo G; Di Clemente D; Giombolini C; Lioy E; Tubaro M
    Am J Cardiol; 2009 Mar; 103(6):796-800. PubMed ID: 19268734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes.
    Melloni C; Peterson ED; Chen AY; Szczech LA; Newby LK; Harrington RA; Gibler WB; Ohman EM; Spinler SA; Roe MT; Alexander KP
    J Am Coll Cardiol; 2008 Mar; 51(10):991-6. PubMed ID: 18325437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.